Foti Nuclear Pharmacy entered the industry of Radioactive Diagnostic Substances in 1989 and has grown to employ 1 to 4 people, generating an annual revenue of $10.000.000 to $19.9999.999. The NAICS classifies this business under the code 3254130, which describes it as a Radioactive Diagnostic Substances. For further clarification, the SIC classifies this business under the code 2835 and described it as a Radioactive Diagnostic Substances. The business provides service to the B2B market.
To acquire more information, please contact Ken Foti by calling (318) 445-7894 during business hours. You can also write to the business’ Single Location at 3325 Giamanco St, Alexandria, Louisiana LA 71301. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Foti Nuclear Pharmacy |
| Representative: | Ken Foti |
| Place of Business: | 3325 Giamanco St, Alexandria, LA 71301 |
| Contact Number: | (318) 445-7894 |
| Type of Service: | Radioactive Diagnostic Substances |
| SIC Number: | 2835 |
| NAICS Number: | 3254130 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 1989 |
| Income/Year: | $10.000.000 to $19.9999.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Foti Nuclear Pharmacy is a company operating from Rapides, Louisiana providing professional Radioactive Diagnostic Substances and relevant B2B variables. It was founded in 1989 and registered with the SIC code 2835 as Radioactive Diagnostic Substances, and with the NAICS code 3254130 as Radioactive Diagnostic Substances.
With a current employee count of 1 to 4, Foti Nuclear Pharmacy has gone to report making $10.000.000 to $19.9999.999 per annum on its journey towards growth. This company invites you to contact its representative Ken Foti at (318) 445-7894 for related queries, or to locate its Single Location using the coordinates 31.28894,-92.47386.
The Single Location can also be found at the street address 3325 Giamanco St in Alexandria, Louisiana 71301 and can be engaged online through the company website at , the company Twitter , and Facebook page .